Weight Loss

If you've struggled to lose weight despite your best efforts with diet and exercise, you're not alone. Many individuals face challenges due to factors such as genetics, hormones, metabolism, insulin resistance, or underlying health conditions.

GLP-1 medications can help by reducing appetite, slowing digestion, improving blood sugar regulation, and helping you feel fuller for longer. When combined with a balanced nutrition plan, regular physical activity, and ongoing medical support, these medications can help promote sustainable weight loss, preserve overall health, and support long-term lifestyle changes.

Schedule a consultation today to learn if GLP-1 medications may be right for you.

Our experienced providers will create a personalized treatment plan tailored to your needs, combining medical weight loss therapy with nutrition, exercise, and ongoing support to help you achieve lasting results.

Weight Loss Medications:

Semaglutide

Semaglutide is a GLP-1 receptor agonist that works by reducing appetite, slowing gastric emptying, and improving blood sugar regulation. These effects help increase feelings of fullness, reduce cravings, and support consistent, sustainable weight loss when paired with healthy nutrition and lifestyle habits.

Tirzepatide

Semaglutide is a GLP-1 receptor agonist that works by reducing appetite, slowing gastric emptying, and improving blood sugar regulation. These effects help increase feelings of fullness, reduce cravings, and support consistent, sustainable weight loss when paired with healthy nutrition and lifestyle habits.

Tirzepatide is a dual GIP and GLP-1 receptor agonist that targets multiple pathways involved in appetite control and metabolic function. It helps reduce hunger, increase satiety, and improve blood sugar balance, often resulting in significant weight loss and improved overall metabolic health.

RTT (GLP-3)

RTT is an investigational medication being studied for chronic weight management. It is not yet approved by the U.S. Food and Drug Administration (FDA), but clinical trials have shown promising results, with many participants achieving significant weight loss and improvements in blood sugar control. Unlike semaglutide and tirzepatide, RTT activates three hormone receptors: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. This triple-receptor approach is designed to reduce appetite, increase feelings of fullness, improve insulin function, and enhance the body's energy expenditure and fat metabolism.

Ready to illuminate your health?

Take the first step toward a healthier, more vibrant you. Start your personalized plan today.

SCHEDULE NOW